Related Experiment Video
Updated: Feb 10, 2026

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
The role of chemokines in atherosclerosis
1Cardiology Division, Department of Medicine, University Hospital, Geneva Medical School, Foundation for Medicale Researches, 64 Avenue Roseraie, Geneva CH-1211, Switzerland. machF@cmu.unige.ch
Insights
Chemokines, crucial for leukocyte recruitment in atherosclerosis, are key targets for future therapies. Understanding chemokine receptor/ligand interactions offers new avenues for preventing and treating this inflammatory disease.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Atherosclerosis involves chronic inflammation and fibroproliferation.
- Leukocyte recruitment and cell activity within lesions are central to the disease.
- Chemokines are known to be present in atherosclerotic lesions and control leukocyte attraction.
Purpose of the Study:
- To investigate the role of chemokines and their receptors in atherosclerosis development.
- To explore chemokines' influence beyond leukocyte chemotaxis in the atherosclerotic process.
- To identify chemokine receptor/ligand interactions as potential therapeutic targets.
Main Methods:
- Utilized knockout and transgenic murine models.
- Documented the presence and function of chemokines within atherosclerotic lesions.
- Analyzed chemokine effects on smooth muscle cell migration, growth, and platelet activation.
Main Results:
- Chemokine receptor/ligand interactions are critical for atherosclerosis development.
- Chemokines influence not only leukocyte migration but also smooth muscle cell behavior and platelet activation.
- Chemokines are significant vascular signals offering insights into atherosclerosis mechanisms.
Conclusions:
- Chemokines play a multifaceted role in the pathogenesis of atherosclerosis.
- Targeting chemokine receptor/ligand pathways presents a promising therapeutic strategy for atherosclerosis.
- Further research into chemokines could lead to novel interventions for atherosclerosis control.
Abstract:
Recruitment of mononuclear leukocytes and the migration, growth, and activation of the multiple cell types within atherosclerotic lesions are critical features of the chronic inflammatory and fibroproliferative response central to atherosclerosis. Attraction of leukocyte to tissues is controlled by chemokines, whose presence is well documented in atherosclerotic lesions. Studies using knockout and transgenic murine models have demonstrated that chemokine receptor/ligand interactions are of crucial importance in the development of atherosclerosis. Beyond their chemotactic effect on mononuclear leukocytes, chemokines may also interfere with smooth muscle cell migration and growth, as well as platelet activation and other well-defined features of the atherosclerotic process. There is no doubt that the identification of chemokines as important vascular signals has provided insights into our understanding of basic cellular and molecular mechanism of atherosclerosis. Thus, there is evidence that chemokine receptor/ligands could be identified as potential new targets for therapeutic intervention to prevent or control atherosclerosis in the near future.
Related Concept Videos
The Role of Culture
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...

